BioNTech SE (BNTX) Liabilities and Shareholders Equity (2018 - 2025)

BioNTech SE (BNTX) has 8 years of Liabilities and Shareholders Equity data on file, last reported at $25.6 billion in Q4 2025.

• In Q4 2025, Liabilities and Shareholders Equity rose 6.32% year-over-year to $25.6 billion; the TTM figure through Dec 2025 stood at $97.3 billion (up 0.53% YoY), while the FY2025 annual figure was $24.8 billion, up 3.19% from the prior year.
• Liabilities and Shareholders Equity climbed to $25.6 billion in Q4 2025, from $24.9 billion in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $25.6 billion in Q4 2025 and bottomed at $5.1 billion in Q1 2021.
• A 5-year average of $21.7 billion and a median of $23.8 billion in 2022 frame the typical range for Liabilities and Shareholders Equity.
• Annual changes were most pronounced in 2021 — Liabilities and Shareholders Equity soared 927.56% — and 2025, when it declined 7.85%.
• Year by year, Liabilities and Shareholders Equity stood at $18.1 billion in 2021, then surged by 31.15% to $23.8 billion in 2022, then increased by 4.22% to $24.8 billion in 2023, then dropped by 2.74% to $24.1 billion in 2024, then increased by 6.32% to $25.6 billion in 2025.
• The last three Liabilities and Shareholders Equity figures came in at $25.6 billion (Q4 2025), $24.9 billion (Q3 2025), and $24.5 billion (Q2 2025), per Business Quant data.

Peer Comparison